The incorporation of homologous and heterologous hypoxanthine-guanine phosphoriboxyltransferase into mutant cells.
Experiments are described leading to partial compensation of a deficiency in the enzyme hypoxanthine-guanine phosphoribosyltransferase in mutant cells by supplying the cells with exogenous purified enzymes. DEAE-dextran is an effective helper agent, whereas poly (L-lysine), lysolecithin and amphotericin B seem to inhibit the entry of the enzymes of their activity. Enzyme preparation from Chinese hamster was found to have different effects in different mutant cell lines. In mutant Chinese hamster cells, the electrophoretic activity pattern remains unchanged for the Chinese hamster enzyme, but changes progressively to faster-moving activity peaks for the human enzyme after several hours. The metabolic effect of the incorporated enzyme is in the range between 3 and 4% of the normal cellular enzyme activity which corresponds to a 10--20 fold increase of hypoxanthine-guanine phosphoribosyltransferase activity in the mutant cells.
D000666:Amphotericin B / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D006224:Cricetinae; D003637:DEAE-Dextran / Q000494:pharmacology; D004912:Erythrocytes / Q000201:enzymology; D007041:Hypoxanthine Phosphoribosyltransferase / Q000172:deficiency / Q000378:metabolism*; D007042:Hypoxanthines / Q000378:metabolism; D007700:Kinetics; D009154:Mutation; D011107:Polylysine / Q000494:pharmacology
D007042:Hypoxanthines; D011107:Polylysine; D000666:Amphotericin B; D003637:DEAE-Dextran; D007041:Hypoxanthine Phosphoribosyltransferase